Evaluation of the efficacy and tolerance of Loma Lux Psoriasis, solution for oral use.
Effective in 83.3% of all patients. It has a positive effect on all forms of psoriasis. There were no side effects during treatment.
Psoriasis
Report on the results of clinical trials on a homeopathic drug, Loma Psoriasis, used for the treatment of psoriasis patients.
After 4 weeks, 85% of patients attachment experienced improvement. After 12 weeks, 100% of patients experienced improvement, with 70% experiencing a total remission of psoriasis symptoms. In 70% of patients, exfoliation stopped completely, psoriasis papules and plaques disappeared and in these places only a greyish brown pigmentation remained.
Psoriasis
Elevated Serum Nickel Concentration in Psoriasis Vulgaris.
Recognition of abnormal attachment nickel homeostasis could point the way to greater understanding of the primary biochemical defect in the psoriatic process. Further investigation is needed.
Psoriasis
Improvement of Psoriasis Vulgaris w/Oral Nickel Dibromide
Patients receiving active treatment improved more than those taking the placebo to a statistically significant degree.
Psoriasis
Oral Supplementation of Nickel & Bromide in Psoriasis Vulgaris Using Nickel Dibromide & Sodium Bromide
The high degree of overall effectiveness documented in this study, when combined with an excellent safety profile documented in this and previous studies on oral nickel bromide administration in humans, suggests that this therapy is useful in treating the psoriatic skin, scalp and nail condition. Overall Mean PASI score after 16 weeks: 87% moderate to marked improvement.
Use this section to provide a concise description of your product's details. Share information about its appearance, materials, colors, sizing options, and manufacturing origin. Highlight its visual appeal, tactile qualities, and unique design features.
